The oldest in Hubei!75 -year -old elderly people successfully accept autologous hematopoietic stem cell transplantation

Jimu Journalist Chen Lingyan

Correspondent Li Yan Yu Xinyi

Intern Huang Zhigao

75 -year -old college teachers unfortunately suffered from advanced lymphoma, and their lives were in danger. Doctors took the treatment of self -hematopoietic stem cell transplantation for him and successfully completed transplantation. Review on July 12 showed that his blood indicators resumed normal, and he became the oldest patients with the oldest autologous hematopoietic stem cell transplantation in Hubei Province.

The age of 75 is the "ceiling" of autologous transplantation. He decided to fight for himself

Mr. Chang is 75 years old. He is a retired teacher. According to him, his body has always been pretty good. Until October last year, he began to appear dizzy and often felt unhappy. He went to the Central South Hospital of Wuhan University.

Blood protein, platelets and other indicators have abnormalities. Doctors believe that he is likely to have blood diseases. Subsequently, he experienced bone marrow puncture and other examinations, and was quickly diagnosed with advanced lymphoma, and molecular detection prompts were high -risk types.

At the end of October of the same year, he began to receive a five -month chemotherapy. After chemotherapy, the condition began to relieve, but for Mr. Chang, he had factors such as the old age and high -risk of the late tumor. Field anti -flutter.

The medical staff sent flowers to Mr. Chang and congratulated him to get a new life

Professor Zhou Fuling, director of the Department of Hematology of the hospital, has been paying attention to the treatment of Mr. Chang. She repeatedly evaluated Mr. Chang's physical condition and condition, and then she made a suggestion: autologous hematopoietic stem cell transplantation.

What is autologous hematopoietic stem cell transplantation? To put it simply, it is to mobilize the hematopoietic stem cells first, complete cell collection, and then perform large -dose chemotherapy, and then lose its own stem cells to achieve the purpose of rebuilding blood and immunity. Because the transplantation uses the patient's own hematopoietic stem cells, the body has no rejection reaction after transplantation, and the transplantation power is high.

However, after all, Mr. Chang is already 75 years old. In addition, the disease has caused the body function to decline, and the tolerance for treatment is relatively weak. These are the factors that affect the success of transplantation.

The age of 75 is the highest age that this therapy is currently successfully used in China. If Mr. Chang agrees to accept autologous hematopoietic stem cell transplantation, he will become the oldest autologous hematopoietic stem cell transplantation.

"If you choose to transplant, there is still the opportunity to continue to live; if you give up, your life will enter the countdown." After 2 days of careful consideration, Mr. Chang and his wife decided to adopt the proposal of transplantation and "fight" with the medical care. Mr. Chang cooperates with medical staff to carry out stem cell mobilization, collection, freezing and other work.

On May 9 this year, he entered the transplantation warehouse of the blood internal flow ward.

Doctors of transplant warehouses send "encouragement" every day, and he overcome the difficulties and welcomes rebirth

The transplantation warehouse is a sterile environment. Before entering, it must be strictly disinfected. After the patient lives in, relatives cannot visit.

In order to allow Mr. Chang, who lives alone in the isolated warehouse, can relax, Zhou Fuling and doctors Zhou Yi, as well as medical staff such as the head nurse Li Jianfang and Wang Cong, will come to the warehouse every day. encourage".

On May 19, Mr. Chang accepted the autologous hematopoietic stem cells.

“常老师，你的干细胞输注过程很顺利，这段时间你好好休息，有不舒服就随时告诉我们，我们来想办法！”在这个阶段，医护人员更多地“来访”，通过话筒与Mr. Chang conducts exchanges, strengthens nursing and does strict monitoring and observation.

The recovery period after transplantation is not easy. Mr. Chang has appeared nauseous nausea and low fever for many consecutive days.

On June 8, Mr. Chang went out smoothly. The examination on July 12 showed that his blood indicators have returned to normal.

"Congratulations!" Zhou Fuling and other medical staff set up a large bouquet of flowers to congratulate Mr. Chang for his new life.

Mr. Chang said excitedly that although he spent a whole month in the transplant warehouse, the medical staff had always given him detailed care and warm encouragement, so that he could understand that he was "not fighting alone." He also believes that he will go through the difficulties smoothly.

"In addition to advanced transplantation technology, the understanding and support of patients and family members, and the smooth and harmonious communication between doctors and patients is also an important factor in the success of transplantation." Zhou Fuling said that cellular lymphoma is one of the most clinical prognosis of lymphoma. Hematopoietic stem cell transplantation has been proposed by the international lymphoma diagnosis and treatment guidelines including the National Cancer Integrated Network (NCCN), as a first -line consolidation treatment plan for patients with high -risk invasion lymphoma. Under normal circumstances, the age of 65 is the age of autologous hematopoietic stem cell transplantation. In recent years, the number of elderly patients with hematological diseases has gradually increased. After accepting the whole body state assessment of patients over 65 years of age, patients who need to accept transplantation or have a strong desire for transplantation under the condition of conditions are allowed. Mr. Chang, who was 75 -year -old, successfully completed the transplantation, has enhanced the confidence of medical staff.

(The picture is provided by Wu Da Zhongnan Hospital)

- END -